About
Digestive enzyme device
Areas of Focus
Categories
Drug Delivery DeviceBoston & New England
Team (15)
Bill Scheinler
Chief Legal and Compliance Officer and Secretary
Alcresta Therapeutics
team_member
Chris Arnold
Chief Commercial Officer
Alcresta Therapeutics
team_member
Chris Parrish
Chief Operating Officer
Alcresta Therapeutics
executive
Daniel Orlando
Chief Executive Officer, Alcresta Therapeutics
Alcresta Therapeutics
executive
Ernest Waaser
Operating Partner, Linden Capital Partners
Alcresta Therapeutics
team_member
Greta Loring
VP, Research and New Product Development
Alcresta Therapeutics
executive
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
2
As Collaborator
4
Total Enrollment
239
By Phase
NA: 4PHASE3: 1
By Status
RECRUITING: 3COMPLETED: 2ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05710315Collaborator
Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure
NARecruiting
32 participants
Started: May 7, 2025 · Completed: Mar 2, 2026
NCT06691893Collaborator
Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients
PHASE3Recruiting
60 participants
Started: Mar 28, 2025 · Completed: Jul 15, 2027
NCT05635747Collaborator
A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
N/AEnrolling by invitation
32 participants
Started: Sep 29, 2022 · Completed: Sep 29, 2027
NCT03530852Collaborator
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
NARecruiting
32 participants
Started: Nov 21, 2018 · Completed: Sep 30, 2028
NCT02750501Lead Sponsor
Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study
NACompleted
49 participants
Started: Jul 20, 2016 · Completed: Mar 30, 2017
Locations (1)
Headquarters
Waltham, MA, United States
Map
Loading map...